hotspot -WSS

hotspot

author：focus 2025-09-03 03:44:04 - browse：7168

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： There's no autism epidemic. It's an autism diagnosis epidemic

entertainment

WSS

RSV vaccines may be linked to small increased risk of developing GBS

Roche subsidiary Foundation Medicine opens new headquarters

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Eliminate the waiting period for sterilization covered by Medicaid

Study says nonprofit hospitals fall short in charity care spending

Merck drug for rare lung condition set for approval in U.S.

hotspot

hotspot

hotspot

The high cost of giving birth even with insurance

Congress gives doctors Medicare pay bump

At least 13 dead in Texas as scorching temps continue

Biotech companies concerned about China biosecurity crackdown

Malaria cases in Florida and Texas: Here’s what you need to know

Abortion pill case raises question: who can sue the FDA?

United colonoscopy coverage change 'may cost lives,' doctors say

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Guidelines to prevent youth baseball injuries need more muscle

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

explore

Why the world’s most expensive drug might be worth the price

Covid isolation guidance eased by the CDC

Medical device lobby: We're tired of waiting on Medicare coverage

FDA's naming rule on biosimilars has undermined competition

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Donor acceptance rates hint at racial, gender bias in heart transplants: study

focus

entertainment

explore

leisure time